ADVERTISEMENT
Subscribe
Menu
Login
Login
Subscribe
News & Opinion
Publications
AN INTERACTIVE EXPERIENCE
Current Issue
December 2024, Issue 1
View This Issue
Archives
Features
Quarterly Magazine
Current Issue
September 2024
View This Issue
Archives
Features
Categories
Biochemistry
Cancer
Cell & Molecular Biology
Community
Drug Discovery & Development
Environment
Evolutionary Biology
Genetics
Immunology
Microbiology
Neuroscience
Physiology
Public Health
Zoology
TS University
Scientific Services
Brush Up Summaries
Technique Talks
Journal Club
TS SciComm
Multimedia
Crossword Puzzles
eBooks
Infographics
Podcasts
Research Products Blog
Research Articles
Science Snapshot
Slideshows
Videos
Words for Nerds
Innovation Spotlight
Webinars
ADVERTISEMENT
Home
Subjects
KEYNOTE
KEYNOTE
Immune Therapy Improves Lung Cancer Patients’ Survival
Jim Daley
| Apr 16, 2018
| 2 min read
Pembrolizumab combined with chemotherapy nearly doubles survival rates and shrinks tumors in some individuals.
ADVERTISEMENT
